ASX - By Stock
|
CUV |
Re:
Ann: Board Changes after AGM
|
|
skram1182
|
11 |
6.4K |
0 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
11
|
6.4K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CEO Letter to Shareholders
|
|
skram1182
|
48 |
19K |
1 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
48
|
19K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CEO Letter to Shareholders
|
|
skram1182
|
48 |
19K |
1 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
48
|
19K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
skram1182
|
18 |
7.4K |
0 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
18
|
7.4K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
skram1182
|
18 |
7.4K |
1 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
18
|
7.4K
|
1
|
|
ASX - By Stock
|
TGP |
Re:
Ann: Update - Notification of buy-back - TGP
|
|
skram1182
|
2 |
507 |
1 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
2
|
507
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Request for extension of voluntary suspension
|
|
skram1182
|
12 |
4.4K |
8 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
12
|
4.4K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
skram1182
|
18 |
7.4K |
1 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
18
|
7.4K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
skram1182
|
20 |
9.0K |
5 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
20
|
9.0K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
skram1182
|
20 |
9.0K |
8 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
20
|
9.0K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
skram1182
|
20 |
9.0K |
0 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
20
|
9.0K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
skram1182
|
20 |
9.0K |
2 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
20
|
9.0K
|
2
|
|
ASX - By Stock
|
TGP |
Re:
Share buy back
|
|
skram1182
|
9 |
2.2K |
0 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
9
|
2.2K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
skram1182
|
20 |
9.0K |
0 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
20
|
9.0K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: FY23 Full year results investor presentation
|
|
skram1182
|
29 |
17K |
1 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
29
|
17K
|
1
|
|
ASX - By Stock
|
TGP |
Re:
Ann: Change of Director's Interest Notice
|
|
skram1182
|
8 |
1.5K |
0 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
8
|
1.5K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: EGM Presentation
|
|
skram1182
|
10 |
3.0K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
10
|
3.0K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: EGM Presentation
|
|
skram1182
|
10 |
3.0K |
3 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
10
|
3.0K
|
3
|
|
ASX - By Stock
|
HPI |
Re:
Ann: Investor Presentation - 30 June 2023
|
|
skram1182
|
13 |
5.6K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
13
|
5.6K
|
1
|
|
ASX - By Stock
|
TGP |
Re:
Ann: Change of Director's Interest Notice
|
|
skram1182
|
8 |
1.5K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
8
|
1.5K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE in Adolescent EPP Study
|
|
skram1182
|
10 |
5.5K |
3 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
10
|
5.5K
|
3
|
|
ASX - By Stock
|
AHX |
Re:
Ann: Change of Director's Interest Notice - C Richards
|
|
skram1182
|
2 |
1.3K |
3 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
2
|
1.3K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE in Adolescent EPP Study
|
|
skram1182
|
10 |
5.5K |
11 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
10
|
5.5K
|
11
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE in Adolescent EPP Study
|
|
skram1182
|
10 |
5.5K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
10
|
5.5K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Ann: MVP Announces FY23 Full Year Results
|
|
skram1182
|
17 |
6.7K |
7 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
17
|
6.7K
|
7
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Half Yearly Report and Accounts
|
|
skram1182
|
8 |
2.5K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
8
|
2.5K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Investor Webinar Transcript
|
|
skram1182
|
7 |
3.6K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
7
|
3.6K
|
0
|
|
ASX - By Stock
|
MME |
Re:
Ann: FY23 Full Year Results Investor Presentation
|
|
skram1182
|
17 |
6.9K |
3 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
17
|
6.9K
|
3
|
|
ASX - By Stock
|
MME |
Re:
Ann: FY23 Full Year Results Announcement
|
|
skram1182
|
13 |
6.5K |
3 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
13
|
6.5K
|
3
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Half Yearly Report and Accounts
|
|
skram1182
|
8 |
2.5K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
8
|
2.5K
|
2
|
|
ASX - By Stock
|
TGP |
Re:
Share buy back
|
|
skram1182
|
9 |
2.2K |
0 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
9
|
2.2K
|
0
|
|
ASX - By Stock
|
TGP |
Share buy back
|
|
skram1182
|
9 |
2.2K |
0 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
9
|
2.2K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report to Shareholders 2023
|
|
skram1182
|
19 |
11K |
10 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
19
|
11K
|
10
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dosing completion in Phase 1A brain cancer clinical trial
|
|
skram1182
|
34 |
10K |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
34
|
10K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report to Shareholders 2023
|
|
skram1182
|
19 |
11K |
1 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
19
|
11K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report to Shareholders 2023
|
|
skram1182
|
19 |
11K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
19
|
11K
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report to Shareholders 2023
|
|
skram1182
|
19 |
11K |
4 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
19
|
11K
|
4
|
|
ASX - By Stock
|
HPI |
Re:
Ann: Investor Presentation - 30 June 2023
|
|
skram1182
|
13 |
5.6K |
1 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
13
|
5.6K
|
1
|
|
ASX - By Stock
|
TGP |
Re:
Ann: FY23 Results Presentation
|
|
skram1182
|
4 |
1.3K |
0 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
HPI |
Re:
Ann: Investor Presentation - 30 June 2023
|
|
skram1182
|
13 |
5.6K |
1 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
13
|
5.6K
|
1
|
|
ASX - By Stock
|
TGP |
Re:
Ann: FY23 Results Presentation
|
|
skram1182
|
4 |
1.3K |
0 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
GEM |
Re:
Ann: Dividend/Distribution - GEM
|
|
skram1182
|
5 |
2.3K |
0 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
5
|
2.3K
|
0
|
|
ASX - By Stock
|
TGP |
Re:
Ann: Buyback
|
|
skram1182
|
31 |
7.0K |
0 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
31
|
7.0K
|
0
|
|
ASX - By Stock
|
TGP |
Re:
Ann: Buyback
|
|
skram1182
|
31 |
7.0K |
0 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
31
|
7.0K
|
0
|
|
ASX - By Stock
|
TLS |
Re:
Ann: TLS - Full year financial results year ended 30 June 2023
|
|
skram1182
|
9 |
6.4K |
6 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
9
|
6.4K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to receive A$4.4 million introduction fee
|
|
skram1182
|
25 |
10K |
3 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
25
|
10K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
skram1182
|
506 |
228K |
2 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
506
|
228K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to receive A$4.4 million introduction fee
|
|
skram1182
|
25 |
10K |
2 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
25
|
10K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
CHM MERGE with ALA & IMU takeover them
|
|
skram1182
|
6 |
2.6K |
1 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
6
|
2.6K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
skram1182
|
11 |
2.8K |
1 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
11
|
2.8K
|
1
|
|